Ryan Low

4.5k total citations · 3 hit papers
15 papers, 2.1k citations indexed

About

Ryan Low is a scholar working on Neurology, Infectious Diseases and Clinical Psychology. According to data from OpenAlex, Ryan Low has authored 15 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 3 papers in Infectious Diseases and 3 papers in Clinical Psychology. Recurrent topics in Ryan Low's work include COVID-19 Clinical Research Studies (3 papers), Complement system in diseases (3 papers) and Long-Term Effects of COVID-19 (3 papers). Ryan Low is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Complement system in diseases (3 papers) and Long-Term Effects of COVID-19 (3 papers). Ryan Low collaborates with scholars based in United Kingdom, United States and Australia. Ryan Low's co-authors include Athena Akrami, Signe Redfield, Lisa McCorkell, Jared P. Austin, Hannah Davis, Yochai Re’em, Gina Assaf, Hannah Wei, David W. Tank and Yi Gu and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Ryan Low

13 papers receiving 2.1k citations

Hit Papers

Characterizing long COVID in an international cohort: 7 m... 2021 2026 2022 2024 2021 2021 2023 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
    2021 1.7k citations Hannah Davis, Gina Assaf et al. EClinicalMedicine profile →
  2. Geometry of abstract learned knowledge in the hippocampus
    2021 158 citations Edward H. Nieh, Manuel Schottdorf et al. Nature profile →
  3. A review of cytokine-based pathophysiology of Long COVID symptoms
    2023 87 citations Russell N. Low, Ryan Low et al. Frontiers in Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Low United Kingdom 9 1.6k 745 551 477 377 15 2.1k
Athena Akrami United States 17 1.8k 1.1× 837 1.1× 600 1.1× 545 1.1× 428 1.1× 26 2.7k
Clotilde Boulay France 8 1.7k 1.1× 464 0.6× 1.1k 1.9× 464 1.0× 151 0.4× 15 2.4k
David García‐Azorín Spain 25 1.2k 0.7× 511 0.7× 425 0.8× 166 0.3× 1.0k 2.7× 148 2.2k
Ayush Batra United States 18 1.0k 0.6× 306 0.4× 401 0.7× 326 0.7× 305 0.8× 54 1.8k
Chaoyue Wang China 13 758 0.5× 283 0.4× 235 0.4× 188 0.4× 121 0.3× 31 1.3k
Wanzhu Bai China 11 1.4k 0.8× 402 0.5× 1.0k 1.9× 139 0.3× 113 0.3× 40 2.0k
Bernd Taschler United Kingdom 9 679 0.4× 242 0.3× 230 0.4× 185 0.4× 119 0.3× 13 1.1k
Frederik Lange United Kingdom 7 688 0.4× 244 0.3× 229 0.4× 187 0.4× 103 0.3× 12 1.0k
Adam H. Dyer Ireland 18 359 0.2× 173 0.2× 233 0.4× 149 0.3× 246 0.7× 48 1.3k
Ángel L. Guerrero Spain 26 907 0.6× 293 0.4× 230 0.4× 70 0.1× 1.6k 4.2× 255 2.7k

Countries citing papers authored by Ryan Low

Since Specialization
Citations

This map shows the geographic impact of Ryan Low's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Low with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Low more than expected).

Fields of papers citing papers by Ryan Low

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Low. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Low. The network helps show where Ryan Low may publish in the future.

Co-authorship network of co-authors of Ryan Low

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Low. A scholar is included among the top collaborators of Ryan Low based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Low. Ryan Low is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chen, Daniel, Maeve O’Reilly, Ryan Low, et al.. (2024). CD19‐targeting chimeric antigen receptor T‐cell therapy is safe and effective for intra‐cardiac B cell non‐Hodgkin lymphoma. SHILAP Revista de lepidopterología. 5(6). 1283–1289. 1 indexed citations
2.
Lohse, Michael, et al.. (2024). Brain-wide dynamics linking sensation to action during decision-making. Nature. 634(8035). 890–900. 19 indexed citations
3.
Robinson, Tonya, et al.. (2024). Treatment for Neonatal Abstinence Syndrome Using Nonpharmacological Interventions. American Journal of Perinatology. 41(16). 2198–2205.
4.
Low, Russell N., Ryan Low, & Athena Akrami. (2023). A review of cytokine-based pathophysiology of Long COVID symptoms. Frontiers in Medicine. 10. 1011936–1011936. 87 indexed citations breakdown →
5.
Nieh, Edward H., Manuel Schottdorf, Ryan Low, et al.. (2021). Geometry of abstract learned knowledge in the hippocampus. Nature. 595(7865). 80–84. 158 indexed citations breakdown →
6.
Davis, Hannah, Gina Assaf, Lisa McCorkell, et al.. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 38. 101019–101019. 1687 indexed citations breakdown →
7.
Davis, Hannah, Gina Assaf, Lisa McCorkell, et al.. (2021). Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. SSRN Electronic Journal. 39 indexed citations
8.
Thomas, Mari, Nishkantha Arulkumaran, Ferras Alwan, et al.. (2020). Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease. Blood. 136(Supplement 1). 27–27. 1 indexed citations
9.
Arulkumaran, Nishkantha, Mari Thomas, David Brealey, et al.. (2020). Plasma exchange for COVID‐19 thrombo‐inflammatory disease. SHILAP Revista de lepidopterología. 2(1). 26–32. 24 indexed citations
10.
Michalarea, Vasiliki, Ryan Low, Amy A. Kirkwood, et al.. (2019). EXCELLENT OUTCOMES USING RITUXIMAB, GEMCITABINE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE (R‐GCVP) IN PATIENTS WITH DLBCL AND CARDIAC COMORBIDITIES. Hematological Oncology. 37(S2). 425–426. 1 indexed citations
11.
Stubbs, Matthew, et al.. (2019). Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune‐mediated thrombotic thrombocytopenic purpura. British Journal of Haematology. 185(5). 912–917. 11 indexed citations
12.
Scott, M.J., Ryan Low, Dawn Swan, & Jecko Thachil. (2017). Reintroduction of anticoagulant therapy after intracranial haemorrhage: If and when?. Blood Reviews. 32(3). 256–263. 5 indexed citations
13.
14.
15.
Low, Ryan, Yi Gu, & David W. Tank. (2014). Cellular resolution optical access to brain regions in fissures: Imaging medial prefrontal cortex and grid cells in entorhinal cortex. Proceedings of the National Academy of Sciences. 111(52). 18739–18744. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Athena Akrami Breakdown of academic impact, for papers by Clotilde Boulay Breakdown of academic impact, for papers by David García‐Azorín Breakdown of academic impact, for papers by Ayush Batra Breakdown of academic impact, for papers by Chaoyue Wang Breakdown of academic impact, for papers by Wanzhu Bai Breakdown of academic impact, for papers by Bernd Taschler Breakdown of academic impact, for papers by Frederik Lange Breakdown of academic impact, for papers by Adam H. Dyer Breakdown of academic impact, for papers by Ángel L. Guerrero
Rankless by CCL
2026